Asterias Biotherapeutics Announces Collaboration with Cell Therapy Catapult

By: via Benzinga
Asterias Biotherapeutics, Inc. (NYSE MKT: AST) has signed an agreement with the UK-based Cell Therapy Catapult to advance development of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.